Related Experiment Video
Updated: Jul 20, 2026
09:06
Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Heart failure and statins--why do we need a clinical trial?
M Böhm1, A Hjalmarson, J Kjekshus
1Klinik für Innere Medizin III, Universitätsklinik des Saarlandes, Kirrberger Strasse, 66421 Homburg, Gemany. boehm@med-in.uni-saarland.de
Zeitschrift Fur Kardiologie
|April 2, 2005
Summary
Statins are proven to reduce cardiovascular events. However, their safety and efficacy in chronic heart failure patients require urgent investigation due to potential adverse effects on mitochondrial function.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Statins effectively reduce mortality and morbidity in cardiovascular disease prevention and acute coronary syndromes.
- Pleiotropic effects of statins may directly impact myocardial cells.
- Concerns exist regarding statin use in chronic heart failure (CHF) due to potential negative impacts on mitochondrial function and inverse correlation with LDL levels.
Purpose of the Study:
- To investigate the safety and efficacy of statins in patients with chronic heart failure.
- To address the lack of safety data for statin use in CHF.
Main Methods:
- A controlled, randomized, placebo-controlled trial is proposed.
- The trial will evaluate outcomes in CHF patients receiving statins versus placebo.
Main Results:
- No specific results are presented as the abstract describes a proposed trial.
Conclusions:
- There is an urgent need for a randomized, placebo-controlled trial to establish the safety and efficacy of statins in chronic heart failure.
Related Concept Videos
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...